Skip to content

Evaluation of MR-guided focused ultrasound therapy for focal adenomyosis

Evaluation of MR-guided focused ultrasound therapy for focal adenomyosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067619
Enrollment
Unknown
Registered
2023-01-13
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenomyosis

Interventions

Test group:MR-guided focus ultrasound

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The clinical symptoms of adenomyosis were obvious, the QOL was >=40, and the VAS score was >=6 2. Patients with obvious dysmenorrhea symptoms, with the length of uterus >=7cm 3. Magnetic resonance imaging showed junctional zone >=12mm 4. Adenomyosis lesions were clearly visible in plain MRI images, and the lesion sites should be more than 4cm in thickness and within the ablation range of MRgHIFU 5. Patients who voluntarily participate in follow-up and can complete follow-up 6. Patients can communicate with doctors and express their feelings clearly during treatment

Exclusion criteria

Exclusion criteria: 1. Postmenopausal women 2. Pregnancy status 3. Known or suspected pelvic malignant tumor or precancerous lesion (LDH >220U/L) 4. Extensive abdominal scar, which cannot be avoided by changing the ultrasonic direction to reach the treatment area 5. Local or systemic infection during the active period 6. Unexplained irregular vaginal bleeding 7. History of uterine artery embolization for adenomyosis 8. Those who cannot tolerate the prone position for 4 hours 9. Pelvic metal implants (such as Iuds) cannot or will not be removed 10. Severe claustrophobia

Design outcomes

Primary

MeasureTime frame
uterine volume;non-perfused volume ratio;USF-QOL;dynamic perfusion curve;

Countries

China

Contacts

Public ContactXuntao Yin

Guangzhou Women and Children's Medical Center

xuntaoyin@gmail.com+86 153 2031 9357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026